| Abbreviation | Definition |
| ACE | Angiotensin-converting enzyme |
| ANCOVA | Analysis of covariance |
| ARB | Angiotensin II receptor blocker |
| ASA | Acetylsalicylic acid |
| CABG | Coronary artery bypass grafting |
| CCS | Canadian Cardiovascular Society |
| CI | Confidence interval |
| COPD | Chronic obstructive pulmonary disease |
| CTO | Chronic total occlusion |
| CTO-PCI | Percutaneous coronary intervention for chronic total occlusion |
| ESS | Effective sample size |
| IPTW | Inverse probability of treatment weighting |
| J-CTO | Multicenter CTO Registry of Japan score |
| LAD | Left anterior descending artery |
| LCX | Left circumflex artery |
| LVEF | Left ventricular ejection fraction |
| MACCE | Major adverse cardiac and cerebrovascular event |
| OMT | Optimal medical therapy |
| OR | Odds ratio |
| PCI | Percutaneous coronary intervention |
| pp | Percentage points |
| PS | Propensity score |
| QoL | Quality of life |
| RCA | Right coronary artery |
| SAQ | Seattle Angina Questionnaire |
| SAQ AF | Seattle Angina Questionnaire Angina Frequency domain |
| SD | Standard deviation |
| SMD | Standardized mean difference |
| TIMI | Thrombolysis in Myocardial Infarction |